Company profile: ZebraSci
1.1 - Company Overview
Company description
- Provider of inspections, testing, life cycle management, regulatory, and medical device development services for healthcare, specializing in combination product development and testing (pharma packaging and drug stability), drug device design verification, container closure integrity (CCI) testing, silicone characterization for parenteral containers using FlexHD, and drug delivery device selection and evaluation.
Products and services
- Combination Product Development: Architects custom-engineered drug–device combination products and equips clients with the necessary information to make informed decisions throughout development
- Drug Device Design Verification: Executes verification-driven analytical and functional testing strategies to confirm drug–device design outputs meet defined input requirements in combination product development
- Combination Product Testing: Delivers pharma-grade end-to-end evaluations of packaging and drug stability, including particle generation measurement, drug product stability assessment, and silicone interaction with drug products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ZebraSci
Resilience
HQ: United States
Website
- Description: Provider of technology-driven biomanufacturing solutions expanding access to complex medicines and protecting biopharmaceutical supply chains, delivering cGMP manufacturing from pre-clinical through commercial stages and end-to-end platforms for cell and gene therapies, biologics, vaccines, and nucleic acids, with process development, analytical testing, supply chain management, and modular manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Resilience company profile →
UBC
HQ: United States
Website
- Description: Provider of pharmaceutical support services for life science companies, including evidence development, safety and risk management, patient access, technology solutions, and clinical services. UBC leverages real-world data, technology, and analytics to enhance late-stage research, demonstrate safety, improve access and adherence, and speed therapy initiation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UBC company profile →
PharmaSeek
HQ: United States
Website
- Description: Provider of consulting and training solutions for clinical research sites, helping institutions, investigators, and independent sites decrease study start-up timelines by assuming administrative burdens of research management, including study identification, contract and budget negotiation, coverage analysis, and financial management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaSeek company profile →
PMG Research
HQ: United States
Website
- Description: Provider of integrated clinical research through a network of facilities operating from 12 U.S. metropolitan areas, conducting trials since 1979. Offerings include Accellacare studies on medical conditions such as migraines, post-surgical neuropathy, and COVID-19 vaccines; The Patient Voice feedback program; Lunch and Learn; and Tell a Friend referral program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PMG Research company profile →
Prime Global
HQ: United States
Website
- Description: Provider of medical communications services via a group of seven full-service medical communications agencies and two specialist consultancies, with a people-first focus on creative, innovative science communication.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prime Global company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ZebraSci
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ZebraSci
2.2 - Growth funds investing in similar companies to ZebraSci
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ZebraSci
4.2 - Public trading comparable groups for ZebraSci
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →